Cargando…
Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975786/ https://www.ncbi.nlm.nih.gov/pubmed/35178675 http://dx.doi.org/10.1007/s40262-022-01112-7 |
| _version_ | 1784680441249267712 |
|---|---|
| author | Wojciechowski, Jessica Malhotra, Bimal K. Wang, Xiaoxing Fostvedt, Luke Valdez, Hernan Nicholas, Timothy |
| author_facet | Wojciechowski, Jessica Malhotra, Bimal K. Wang, Xiaoxing Fostvedt, Luke Valdez, Hernan Nicholas, Timothy |
| author_sort | Wojciechowski, Jessica |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8975786 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89757862022-04-07 Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis Wojciechowski, Jessica Malhotra, Bimal K. Wang, Xiaoxing Fostvedt, Luke Valdez, Hernan Nicholas, Timothy Clin Pharmacokinet Correction Springer International Publishing 2022-02-18 2022 /pmc/articles/PMC8975786/ /pubmed/35178675 http://dx.doi.org/10.1007/s40262-022-01112-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Wojciechowski, Jessica Malhotra, Bimal K. Wang, Xiaoxing Fostvedt, Luke Valdez, Hernan Nicholas, Timothy Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis |
| title | Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis |
| title_full | Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis |
| title_fullStr | Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis |
| title_full_unstemmed | Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis |
| title_short | Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis |
| title_sort | correction to: population pharmacokinetics of abrocitinib in healthy individuals and patients with psoriasis or atopic dermatitis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975786/ https://www.ncbi.nlm.nih.gov/pubmed/35178675 http://dx.doi.org/10.1007/s40262-022-01112-7 |
| work_keys_str_mv | AT wojciechowskijessica correctiontopopulationpharmacokineticsofabrocitinibinhealthyindividualsandpatientswithpsoriasisoratopicdermatitis AT malhotrabimalk correctiontopopulationpharmacokineticsofabrocitinibinhealthyindividualsandpatientswithpsoriasisoratopicdermatitis AT wangxiaoxing correctiontopopulationpharmacokineticsofabrocitinibinhealthyindividualsandpatientswithpsoriasisoratopicdermatitis AT fostvedtluke correctiontopopulationpharmacokineticsofabrocitinibinhealthyindividualsandpatientswithpsoriasisoratopicdermatitis AT valdezhernan correctiontopopulationpharmacokineticsofabrocitinibinhealthyindividualsandpatientswithpsoriasisoratopicdermatitis AT nicholastimothy correctiontopopulationpharmacokineticsofabrocitinibinhealthyindividualsandpatientswithpsoriasisoratopicdermatitis |